Eating disorders rise amid popular weight loss medications Wegovy and Zepbound—Is there a link?

News News

Eating disorders rise amid popular weight loss medications Wegovy and Zepbound—Is there a link?
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Liz Szabo is an independent health and science journalist. Her work has won multiple national awards. One of her investigations led to a new state law in Virginia.

Over the past six months, psychologist Tom Hildebrandt has seen an increase in patients with eating disorders who are taking popular weight loss drugs like Wegovy or Zepbound. “They start using this drug and next thing you know, they’ve developed what looks very much like anorexia nervosa,” said Hildebrandt, who leads Mount Sinai’s Center of Excellence in Eating and Weight Disorders in New York City.

“Our physicians are really, really cautious about their prescribing and do a very thorough intake,” Pandit said, adding that her colleagues who prescribe these drugs “sort of interview with potential patients before they’ll propose starting a medicine.” A trigger and a treatment? Pandit said she’s also seen patients with binge eating disorder who have benefited from taking GLP-1 drugs. Dr.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNewsHealth /  🏆 707. in US

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Zepbound Sheds More Weight Than Wegovy, Study FindsZepbound Sheds More Weight Than Wegovy, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »

Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss studyZepbound outperforms Ozempic and Wegovy in head-to-head weight loss studyThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »

Pfizer targets obesity with new once-daily Danuglipron drugPfizer targets obesity with new once-daily Danuglipron drugCurrent FDA approved weight loss meds Wegovy and Zepbound are weekly injections.
Read more »

Love at first bite for competitive eating couple; both preparing for big hot dog eating contestLove at first bite for competitive eating couple; both preparing for big hot dog eating contestThe power couple of competitive eating, Miki Sudo and Nick Wehry, are gearing up for fireworks and frankfurters.
Read more »

Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like ZepboundDrug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like ZepboundScience and Technology News and Videos
Read more »

Drugs Like Ozempic, Wegovy, Zepbound And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking AtDrugs Like Ozempic, Wegovy, Zepbound And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking AtRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »



Render Time: 2025-04-07 23:25:04